Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025)

Benitec Biopharma has disclosed Enterprise Value across 7 years of filings, most recently posting -$188.9 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$188.9 million, down 141.32% year-over-year; the trailing twelve-month figure through Dec 2025 was -$188.9 million (down 141.32% YoY), and the FY2025 annual result was -$97.9 million, down 92.14% from the prior year.
• Enterprise Value came in at -$188.9 million for Q4 2025 at Benitec Biopharma, down from -$94.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$13000.0 in Q1 2024 to a low of -$188.9 million in Q4 2025.
• The 5-year median for Enterprise Value is -$18.2 million (2021), against an average of -$41.9 million.
• Across the five-year window, Enterprise Value jumped 99.8% in 2024 and tumbled 796692.31% in 2025, its largest moves.
• Benitec Biopharma's Enterprise Value stood at -$12.3 million in 2021, then gained by 14.72% to -$10.5 million in 2022, then slumped by 93.91% to -$20.4 million in 2023, then plunged by 283.97% to -$78.3 million in 2024, then slumped by 141.32% to -$188.9 million in 2025.
• The last three Enterprise Value figures came in at -$188.9 million (Q4 2025), -$94.6 million (Q3 2025), and -$97.9 million (Q2 2025), per Business Quant data.